Binding characteristics and sensitivity to endogenous dopamine of [11C]‐(+)‐PHNO, a new agonist radiotracer for imaging the high‐affinity state of D2 receptors in vivo using positron emission tomography

[11C]‐(+)‐PHNO (4‐propyl‐9‐hydroxynaphthoxazine) is a new agonist radioligand that provides a unique opportunity to measure the high‐affinity states of the D2 receptors (D2‐high) using positron emission tomography (PET). Here we report on the distribution, displaceablity, specificity and modeling of...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Journal of neurochemistry Ročník 97; číslo 4; s. 1089 - 1103
Hlavní autori: Ginovart, Nathalie, Galineau, Laurent, Willeit, Matthaeus, Mizrahi, Romina, Bloomfield, Peter M., Seeman, Philip, Houle, Sylvain, Kapur, Shitij, Wilson, Alan A.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Oxford, UK Blackwell Publishing Ltd 01.05.2006
Blackwell
Predmet:
Cat
ISSN:0022-3042, 1471-4159
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:[11C]‐(+)‐PHNO (4‐propyl‐9‐hydroxynaphthoxazine) is a new agonist radioligand that provides a unique opportunity to measure the high‐affinity states of the D2 receptors (D2‐high) using positron emission tomography (PET). Here we report on the distribution, displaceablity, specificity and modeling of [11C]‐(+)‐PHNO and compare it with the well characterized antagonist D2 radioligand, [11C]raclopride, in cat. [11C]‐(+)‐PHNO displayed high uptake in striatum with a mean striatal binding potential (BP) of 3.95 ± 0.85. Pre‐treatment with specific D1 (SCH23390), D2 (raclopride, haloperidol) and D3 receptor (SB‐277011) antagonists indicated that [11C]‐(+)‐PHNO binding in striatum is specific to D2 receptors. Within‐subject comparisons showed that [11C]‐(+)‐PHNO BP in striatum was almost 2.5‐fold higher than that measured with [11C]‐(–)‐NPA ([11C]‐(–)‐N‐propyl‐norapomorphine). Comparison of the dose‐effect of amphetamine (0.1, 0.5 and 2 mg/kg; i.v.) showed that [11C]‐(+)‐PHNO was more sensitive to the dopamine releasing effect of amphetamine than [11C]raclopride. Amphetamine induced up to 83 ± 4% inhibition of [11C]‐(+)‐PHNO BP and only up to 56 ± 8% inhibition of [11C]raclopride BP. Scatchard analyses of [11C]‐(+)‐PHNO and [11C]raclopride bindings in two cats showed that the Bmax obtained with the agonist (29.6 and 32.9 pmol/mL) equalled that obtained with the antagonist (30.6 and 33.4 pmol/mL). The high penetration of [11C]‐(+)‐PHNO in brain, its high signal‐to‐noise ratio, its favorable in vivo kinetics and its high sensitivity to amphetamine shows that [11C]‐(+)‐PHNO has highly suitable characteristics for probing the D2‐high with PET.
Bibliografia:SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ISSN:0022-3042
1471-4159
DOI:10.1111/j.1471-4159.2006.03840.x